Industry Symposium
To B-cell maturation antigen (BCMA) or not to BCMA? Addressing unanswered questions in relapsed refractory multiple myeloma (RRMM)
Thursday 23rd May 2024, 12:30–14:00 CEST
Paris, France
FACULTY
| AGENDA | |
|---|---|
| 12:30 – 12:35 | Welcome and introduction Prof. Jesús San Miguel (Chair) University of Navarra, Spain |
| 12:35 – 12:50 | An expanding landscape: Reviewing the available treatment options in TCE RRMM Prof. Philippe Moreau University Hospital of Nantes, France |
| 12:50 – 13:10 | Who, what and how? Tailoring treatment selection in challenging populations Prof. Paula Rodríguez-Otero University of Navarra, Spain |
| 13:10 – 13:25 | Panel discussion 1: Treatment selection All faculty, moderated by Prof. Jesús San Miguel |
| 13:25 – 13:45 | Time to step up? Optimising T-cell redirecting regimens Dr Roberto Mina University of Torino, Italy |
| 13:45 – 14:00 | Panel discussion 2: Treatment optimisation All faculty, moderated by Prof. Jesús San Miguel |